EU may approve BioNTech and Moderna vaccines as soon as December
The European Medicines Agency is in daily contact with the US Food and Drug Administration about the evaluation of the vaccines
Hong Kong — BioNTech and Moderna could receive conditional EU marketing authorisation for their Covid-19 vaccines in the second half of December, according to the head of the EU’s executive arm, putting the bloc on track to start distributing the shots at the same time as the US.
The European Medicines Agency (EMA) is in daily contact with the US Food and Drug Administration (FDA) about the evaluation of the vaccines to “synchronise” assessment, said European Commission president Ursula von der Leyen. The EMA has said conditional approval could come as early as the second half of December, Von der Leyen told reporters after EU leaders discussed the Covid-19 pandemic via video conference on Thursday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.